What are the 'Big Eight' film studios in the United States?

The original 'Big Eight' Hollywood film studios were Metro-Goldwyn-Mayer (MGM), Paramount Pictures, 20th Century Fox, Warner Bros., United Artists, Universal Pictures, Columbia Pictures, and RKO Radio Pictures. These eight companies founded the Motion Picture Association of America (MPAA), which classifies all films released in the United States and lobbies on behalf of the American film industry. At the time, these eight studios were monopolistic enterprises—especially the top five—which controlled every stage of filmmaking, from production and distribution to exhibition, owning their own theater chains. It was not until the 1950s that, under pressure from U.S. antitrust laws, they were forced to divest their theater chains (though major studios have since re-entered exhibition—e.g., Sony currently holds a 20% stake in the largest U.S. theater chain). The loss of their theater chains, combined with the rise of television, plunged the Big Eight into unprecedented crisis, leading to RKO’s bankruptcy in the 1950s. Disney’s subsequent rise filled the void left by RKO. Hollywood then entered a period of decline; in the 1970s, MGM—the former industry leader—gradually declined and was acquired by United Artists. Yet UA’s fortunes were short-lived: its investment in *Heaven’s Gate*, widely regarded as the most financially disastrous film in cinematic history, triggered UA’s bankruptcy, forcing MGM to step in and restructure the merged entity as MGM/UA—reducing the Big Eight to the Big Seven. Meanwhile, several smaller studios emerged and gained prominence in the 1960s and 1970s—including TriStar Pictures, New Line Cinema, Carolco Pictures, and Orion Pictures—but none achieved the scale or influence of the Big Seven. TriStar and New Line only advanced significantly after being acquired by larger conglomerates. In the early 1980s, Hollywood began recovering amid a wave of major mergers and acquisitions. First, the ailing MGM was acquired by Turner Broadcasting System (TBS), parent company of CNN. Turner already owned New Line and Castle Rock Entertainment (producer of acclaimed films such as *The Shawshank Redemption* and *The Green Mile*). Finding MGM’s assets difficult to integrate, Turner retained only MGM’s most valuable asset—the world’s largest film library—to bolster its television programming (which explains why many MGM/UA classic films’ DVDs are distributed by Warner Bros.), then sold MGM to an Italian financial consortium. The sole consolation for MGM was that Turner did not acquire the James Bond franchise rights. In 1985, even the distribution success of the *Star Wars* trilogy could not save 20th Century Fox from bankruptcy. Australian media magnate Rupert Murdoch’s News Corporation stepped in and acquired the studio. Under News Corp.’s management, Fox not only regained its former glory but also launched the fourth major U.S. television network, FOX. Sony of Japan, having previously acquired CBS Records, purchased Columbia Pictures and TriStar from Coca-Cola in 1989, forming Sony Pictures (Sony Pictures/Columbia-TriStar). Although the newly formed company incurred consecutive annual losses—placing heavy financial strain on Sony—the corporation remained committed and refused to abandon the venture.

What is the specific mechanism and clinical utility of warfarin?

Warfarin (acenocoumarol, also known as coumadin) is an oral anticoagulant, commonly referred to as a 'blood thinner.' In simple terms, it functions as an anticoagulant. It exerts its effect by inhibiting the vitamin K–dependent activation of clotting factors, thereby preventing the formation of new thrombi, halting the extension and propagation of existing clots, and suppressing the development of new thrombi on top of old ones. Simultaneously, it helps prevent thrombus detachment and subsequent embolism, facilitating the resolution of pre-existing thrombi. Warfarin offers several advantages—including a long duration of action, convenient oral administration, relatively mild side effects, and low cost—making it widely used for long-term anticoagulation and prevention in conditions such as post–mechanical heart valve replacement, atrial fibrillation, secondary stroke prevention, deep vein thrombosis (DVT), pulmonary embolism (PE), diabetic nephropathy (DN), and myocardial infarction. It holds an irreplaceable position in oral anticoagulant therapy and remains the drug of first choice in contemporary anticoagulation treatment. Warfarin formulations differ across manufacturers in both dosage strength and tablet color: imported warfarin (produced by Orion Pharma, Finland) comes in 3-mg tablets colored blue, whereas domestically manufactured warfarin (produced by Qilu Pharmaceutical or Shanghai Xinyi Pharmaceutical) is available in 2.5-mg white tablets.

Bank of America Corp Acquires New Position in Orion S.A.

14 hours ago

Bank of America acquired 313,790 shares of Orion Engineered Carbons worth $2.08 million in Q2. Despite higher revenue, Orion missed earnings estimates, leading to a stock decline and a "Strong Sell" analyst consensus.

MarketBeat

2026-09-16

Orion S.A. Plant in France Earns IATF Certification

2026-09-22

Orion Engineered Carbons Receives Automotive Quality Certification in France

2026-10-01

Bank of America Corp Acquires New Position in Orion S.A.

Bank of America Corp Acquires New Position in Orion S.A.

FAQ